Ausgabe 5/2007
Inhalt (23 Artikel)
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
Erica L Mayer, Lisa A Carey, Harold J Burstein
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston
Role of human HGFIN/nmbin breast cancer
Rebecca L Metz, Prem S Patel, Meera Hameed, Margaret Bryan, Pranela Rameshwar
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
Christina Yau, Vita Fedele, Ritu Roydasgupta, Jane Fridlyand, Alan Hubbard, Joe W Gray, Karen Chew, Shanaz H Dairkee, Dan H Moore, Francesco Schittulli, Stefania Tommasi, Angelo Paradiso, Donna G Albertson, Christopher C Benz
BP1 transcriptionally activates bcl-2and inhibits TNFα-induced cell death in MCF7 breast cancer cells
Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
Anna L Stratford, Golareh Habibi, Arezoo Astanehe, Helen Jiang, Kaiji Hu, Eugene Park, Ashleen Shadeo, Timon PH Buys, Wan Lam, Trevor Pugh, Marco Marra, Torsten O Nielsen, Uwe Klinge, Peter R Mertens, Samuel Aparicio, Sandra E Dunn
Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004
Theresa HM Keegan, Ellen T Chang, Esther M John, Pamela L Horn-Ross, Margaret R Wrensch, Sally L Glaser, Christina A Clarke
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E Hynes
Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
Anne Cayre, Florence Mishellany, Nicole Lagarde, Frédérique Penault-Llorca
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J van de Vijver
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer
Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg, Nicole Stahmann, Klaus Pantel
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
Javier A Menendez, Ruth Lupu
P-cadherin expression in breast cancer: a review
Joana Paredes, Ana Luísa Correia, Ana Sofia Ribeiro, André Albergaria, Fernanda Milanezi, Fernando C Schmitt
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion
Deborah L Holliday, Simon Hughes, Jacqueline A Shaw, Rosemary A Walker, J Louise Jones
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
Marc van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault-Llorca, Josef Rüschoff
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling
Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss, Edith C Kordon
Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis
Jos A van der Hage, J Sven D Mieog, Marc J van de Vijver, Cornelis JH van de Velde
Live or let die: oestrogen regulation of survival signalling in endocrine response
Alison J Butt, Robert L Sutherland, Elizabeth A Musgrove
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53codon 72 Arg>Pro polymorphism
Sailesh Gochhait, Syed Irfan Ahmad Bukhari, Narendra Bairwa, Shivani Vadhera, Katayoon Darvishi, Mohammad Raish, Pawan Gupta, Syed Akhtar Husain, Rameshwar NK Bamezai
Dietary intake and breast density in high-risk women: a cross-sectional study
Marilyn Tseng, Celia Byrne, Kathryn A Evers, Mary B Daly
Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study
Yngve Bremnes, Giske Ursin, Nils Bjurstam, Inger T Gram
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer, Jonathan Uhr